USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
RETROJECT, INC.
Address:
1125 PINEHURST DRIVE
CHAPEL HILL, NC 27517-
Phone:
N/A
URL:
N/A
EIN:
146134813
DUNS:
78672324
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $159,063.00 1

Award List:

The Retroject Device: A Novel Approach to Glaucoma Drug Delivery

Award Year / Program / Phase:
2013 / STTR / Phase I
Award Amount:
$159,063.00
Agency:
HHS
Principal Investigator:
Molly M. Walsh – 919-619-3042
Research Institution:
DUKE UNIVERSITY
RI Contact:
Abstract:
PROJECT ABSTRACT Glaucoma is a common neurodegenerative disease which is the 2nd leading cause of blindness in the United States. With the aging baby boomer population, these numbers will continue to increase exponentially over the next few decades. With glaucomatous progression, there is ultimately… More